• KBM

USP Considerations During Pandemic

On 11 April 2020, the United States Pharmacopeia (USP) issued guidance regarding operational considerations during the COVID-19 pandemic. These instructions include assignment of beyond use dates, certifications, and cleaning/disinfecting. The Joint Commission (TJC) has issued declared that "(o)rganizations may utilize these guidelines and remain in compliance with Joint Commission standards until the state of emergency has been lifted at the regional, state or national level."


https://go.usp.org/l/323321/2020-04-11/345w2b


https://www.jointcommission.org/resources/news-and-multimedia/blogs/on-infection-prevention-control/2020/04/29/sterile-compounding-considerations-during-covid-19/


4 views0 comments

Recent Posts

See All

The Centers for Disease Control and Prevention National Safety Healthcare Network (CDC NHSN) published in January guidance for the Patient Safety Component Manual. Please check your specific areas to

Becton, Dickinson and Company have issued a voluntary recall of the 2Hi-Lite Orange™ 26 mL Applicator (2% w/w chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) better known as ChloraP